denotes an abstract that is clinically relevant.
denotes that this is a ticketed session.
Program: Special-Interest Sessions
Hematology Disease Topics & Pathways:
Bleeding and Clotting, Clinical Practice (Health Services and Quality), Clinical Research, health outcomes research, health disparities research, thromboembolism, patient-reported outcomes, Diseases, real-world evidence, thrombotic disorders, Therapies, clinical procedures, Lymphoid Malignancies, Adverse Events, Myeloid Malignancies, Technology and Procedures
Hematology Disease Topics & Pathways:
Bleeding and Clotting, Clinical Practice (Health Services and Quality), Clinical Research, health outcomes research, health disparities research, thromboembolism, patient-reported outcomes, Diseases, real-world evidence, thrombotic disorders, Therapies, clinical procedures, Lymphoid Malignancies, Adverse Events, Myeloid Malignancies, Technology and Procedures
Sunday, December 11, 2022: 4:30 PM-6:00 PM
271-273
(Ernest N. Morial Convention Center)
Chair:
Marc Carrier, MD, MSc, FRCPC, University of Ottawa
Disclosures:
Carrier: Servier: Honoraria; Sanofi: Honoraria; Pfizer: Honoraria, Research Funding; BMS: Honoraria, Research Funding; Leo Pharma: Honoraria, Research Funding.
During this special education session, presenters will discuss the ASH guidelines on the prevention and treatment of venous thromboembolism in patients with cancer.
See more of: Special-Interest Sessions